The convergence of technology and healthcare attracted significant new attention last year, according to research from Dow Jones VentureSource. In 2011, VCs poured $439 million into 70 deals for healthcare startups that develop mobile apps and tools for...

This morning, we announced our fourth quarter and full-year 2011 financial results. Consolidated net loss for the three months ended December 31, 2011 was $24.5 million, or $1.18 per share, compared with net income of $45.1 million, or $2.19 per share,...

As 2011 comes to a close, it offers us an opportunity to look back at the major milestones and key events of the year. While 2011 will be remembered for the life of Steve Jobs, the launch of Google Plus, the European debt crisis, and catchphrases like “occupy,”...

Socrates believed that persistence—above trust, genius, or education—was the characteristic that most frequently led to success. I’ve adhered to that philosophy since I first read it and have applied it to many aspects of my life—both personally...

At Safeguard Scientifics, we offer our partner companies quality resources to promote their growth and help them recruit strong management teams for their future. We currently have 16 partner companies, and we strive to provide each of them with operational...

The past 12 months have exciting at Safeguard Scientifics. In December of 2010, partner companies Clarient and Avid Radiopharmaceuticals were both acquired by giants in the life sciences industry. Safeguard experienced the largest cash return in our 58-year...